Latest filing published 17 Mar 2023 for Skye Bioscience, Inc., €1.5M.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Emerald Health Sciences Inc.: trading record in brief
Emerald Health Sciences Inc. appears in our data through filings on Skye Bioscience, Inc. shares, published by SEC (Form 4). We count 8 filings; the first trade dates from 24 January 2018 and the latest from 22 February 2023.
No open-market sale appears; the market trades are 1 purchase. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
The latest filing, published on 17 March 2023, reports a share grant of €1.5M in Skye Bioscience, Inc. The last insider purchase was made public on 21 February 2018, 3,183 days ago. The median gap between a trade and its publication by SEC (Form 4) is 14 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Emerald Health Sciences Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 41,379,164 shares@ US$0.038634.1% of flowCommon StockSEC:0001567619-23-005234:1
- 16,641,486 shares@ US$0.017100.0% of flowCommon StockSEC:0001567619-23-005234:0
- 40,800,000 sharesCommon StockSEC:0001640334-20-000163:0
- 37,667 sharesCommon StockSEC:0001209191-18-064353:0
- 12,335,000 shares@ US$0.1034.6% of flowCommon StockSEC:0001209191-18-023388:0
- 20,000,000 shares@ US$0.1056.2% of flowCommon StockSEC:0001209191-18-023388:1
- 1,781,250 shares0Common StockSEC:0001209191-18-016047:0
- 15,000,000 sharesCommon StockSEC:0001209191-18-011938:0Canonical exit: 17 May 2018 (T+90)
8 of 8 declarations